Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need

March 10, 2018

Responsive image

PARIS and TARRYTOWN, N.Y., March 10, 2018 /PRNewswire/ — To help ensure more affordable and timely access to patients most in need, Sanofi (EURONEXT: SAN) (NYSE: SNY) and Regeneron Pharmaceuticals, will offer U.S. payers that agree to reduce burdensome access barriers for high-risk patien…

Category: Precious Metals